Back

Developing a Fully Automated Imaging Biomarker for HCC Risk Assessment via MRI-Based Tumor Segmentation and EPM

Twam, A.; Smith, S. A.; Eltaher, M.; Boriek, Z.; Bourgeois, D.; Martinus, D.; Calderone, T. L.; Beretta, L.; Sanchez, J. I.; Victor, D. W.; Gupta, N.; Hassan, M.; Prasun, J. K.; Koay, E. J.; Fuentes, D. T.

2025-11-17 radiology and imaging
10.1101/2025.11.14.25340275 medRxiv
Show abstract

This study investigates the feasibility of using automated tumor segmentation as the region of interest for early detection of hepatocellular carcinoma (HCC) using magnetic resonance imaging (MRI). Enhancement Pattern Mapping (EPM) is used as a voxel-wise imaging biomarker within the region of interest once segmentations are generated. We implement PocketNet, a lightweight convolutional neural network, to segment liver tumors and evaluate performance. To contextualize model accuracy, we estimate the theoretical upper bound of segmentation performance through inter-observer comparisons of manual annotations. Imaging-derived features from automated segmentations are analyzed using XGBoost to assess their predictive value. Results show that automated segmentation approaches upper-bound performance for larger tumors but underperforms on smaller lesions. However, EPM features derived from automated masks demonstrate comparable predictive power to those from manual segmentations, indicating that the EPM features are stable with respect to segmentation inaccuracies. Results demonstrate that a fully automated imaging biomarker may be developed as a clinical utility for HCC risk assessment.

Published in Scientific Reports (predicted rank #1) · training set

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.